Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.99 Down 0.09(1.77%) 4:00PM EDT
|After Hours : 4.99 0.00 (0.00%) 7:22PM EDT
Prev Close:5.08
Open:5.04
Bid:4.97 x 5000
Ask:5.00 x 100
1y Target Est:11.63
Beta:1.78
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.96 - 5.10
52wk Range:4.60 - 7.82
Volume:3,326,868
Avg Vol (3m):3,450,950
Market Cap:580.47M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 1.77%580.47M
ABTDown 1.73%63.26B
GSKDown 0.21%116.18B
RHHBYDown 1.36%246.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):172.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback